Skip to main content

Part of the book series: Infectious Disease ((ID))

  • 1147 Accesses

Abstract

Varicella-zoster virus (VZV) is one of the eight herpesviruseso that infects humans. The virus causes two diseases, varicella (chickenpox) and zoster (shingles) (1). Varicella is primarily an illness of children, although as many as 5% of adults in the United States may be susceptible. Zoster is caused by reactivation of latent VZV infection in sensory ganglia, which resulted during the attack of varicella, usually years to decades previously. VZV is able to cause a persistent infection in sensory ganglia without harm, expressing only 5 of its 70 gene products (2). In the setting of a low cell-mediated immune response to VZV, however, full gene expression can occur, and infectious virus may be formed within ganglia and transferred down the axon to the skin (1). Zoster occurs in about 15% of people over their lifetime. It characteristically occurs despite the presence of high titers of antibodies to VZV. Little more is understood about reactivation of VZV; it occurs most commonly in elderly and immunocompromised populations. Reasons for its development in otherwise healthy young persons are not fully understood, but fortunately it is a rather uncommon occurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arvin A, Gershon A. Live attenuated varicella vaccine. Annu Rev Microbiol 1996;50:59–100.

    Article  PubMed  CAS  Google Scholar 

  2. Lungu O, Panagiotidis C, Annunziato P, Gershon A, Silverstein S. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc Natl Acad Sci U S A 1998;95:7080–7085.

    Article  PubMed  CAS  Google Scholar 

  3. Seward J, Peterson C, Mascola L, et al. Decline of Varicella Disease: Evidence of Vaccine Impact, Vol. 1629. Boston: Society for Pediatric Research, Boston, 2000.

    Google Scholar 

  4. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996;10:571–581.

    Article  PubMed  CAS  Google Scholar 

  5. Krause P, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr 1995;127:518–525.

    Article  PubMed  CAS  Google Scholar 

  6. Sharrar RG, LaRussa P, Galea S, et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000;19:916–923.

    Article  PubMed  CAS  Google Scholar 

  7. Gershon A. Chickenpox, measles, and mumps. In: Remington J, Klein J, eds. Infections of the Fetus and Newborn Infant, 5th ed. Philadelphia: Saunders, 2001:683–732.

    Google Scholar 

  8. LaRussa P, Steinberg S, Seeman MD, Gershon AA. Determination of immunity to varicella by means of an intradermal skin test. J Infect Dis 1985;152:869–875.

    PubMed  CAS  Google Scholar 

  9. Srabstein JC, Morris N, Larke B, deSa D, Oxon DP, Castelino BB, Sum E. Is there a congenital varicella syndrome? J Pediatr 1974;84:239–243.

    Article  PubMed  CAS  Google Scholar 

  10. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548–1551.

    Article  PubMed  CAS  Google Scholar 

  11. Lekstrom-Himes JA, Pesnicak L, Straus SE. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol 1998;72:2760–2764.

    PubMed  CAS  Google Scholar 

  12. Centers for Disease Control and Prevention. Prevention of varicella. MMWR Morb Mortal Wkly Rep 1999;48:1–6.

    Google Scholar 

  13. Meyers J. Congenital varicella in term infants: risk reconsidered. J Infect Dis 1974;129:215–217.

    PubMed  CAS  Google Scholar 

  14. Remington J, Klein JO. Infectious Diseases of the Fetus and Newborn Infant, 4th ed. Philadelphia: Saunders, 2001.

    Google Scholar 

  15. Gershon A. Varicella in mother and infant: problems old and new. In: Krugman S, Gershon A, eds. Infection of the Fetus and Newborn Infant. New York: Liss, 1975:79–95.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Gershon, A.A. (2006). Varicella-Zoster Virus. In: Hutto, C. (eds) Congenital and Perinatal Infections. Infectious Disease. Humana Press. https://doi.org/10.1385/1-59259-965-6:091

Download citation

  • DOI: https://doi.org/10.1385/1-59259-965-6:091

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-297-1

  • Online ISBN: 978-1-59259-965-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics